BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Up 47.5% in July

BetterLife Pharma Inc. (OTCMKTS:BETRF) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 14,600 shares, a growth of 47.5% from the June 30th total of 9,900 shares. Based on an average daily volume of 46,200 shares, the short-interest ratio is presently 0.3 days.

BetterLife Pharma Price Performance

Shares of BETRF remained flat at $0.10 during mid-day trading on Friday. The stock had a trading volume of 36,086 shares, compared to its average volume of 16,125. BetterLife Pharma has a 1 year low of $0.03 and a 1 year high of $0.15. The firm has a market capitalization of $12.38 million, a PE ratio of -3.37 and a beta of 1.25. The company has a 50-day moving average price of $0.10 and a 200 day moving average price of $0.08.

BetterLife Pharma (OTCMKTS:BETRF) last announced its quarterly earnings results on Thursday, June 27th. The company reported ($0.01) earnings per share for the quarter.

About BetterLife Pharma

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.